Skip to main content
UFPT
NASDAQ Industrial Applications And Services

UFP Technologies Q2 Sales Surge 15% to $174M, Margins Expand, but Cash Flow Tightens

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Medical Device Stocks · Healthcare
Sentiment info
Neutral
Importance info
8
Price
$311.87
Mkt Cap
$2.413B
52W Low
$173.86
52W High
$338.71
52W Position info
79% above low
Off High info
7.9% below high
Rel. Volume info
1.0× avg
Market data snapshot near publication time

UFPT sits 79% above its 52-week low of $173.86.

Summary

UFP Technologies posted Q2 2026 revenue of $174 million (+15% YoY) and EPS of $2.68, exceeding expectations, but operating cash flow dropped sharply due to a $30.5 million increase in receivables.


Key Events · Earnings and Guidance · UFPT

  • Q2 Revenue +15% to $174M

    Net sales rose 15.1% to $174.0 million, driven by growth in Surfaces and Support, Cardiovascular, Infection Control, and Orthopedics sub-markets. Organic growth was 12.4%.

  • Margins Expand, EPS Beats

    Gross margin improved to 29.3% from 28.8% a year ago. Diluted EPS of $2.68 compared to $2.21 in Q2 2025, a 21% increase.

  • Operating Cash Flow Halves

    Operating cash flow fell to $18.8 million in H1 2026 from $39.1 million in H1 2025, primarily due to a $30.5 million increase in accounts receivable from higher sales volume.

  • Cash Reserves Dwindle

    Cash and equivalents dropped to $9.0 million at June 30, 2026, from $20.3 million at year-end 2025. Total debt stands at $117.3 million, with $150 million available under the revolving credit facility.


Analysis · UFPT · Industrial Applications And Services

A strong top-line performance lifted sales 15% to $174 million, fueled by medical device demand. Gross margins widened to 29.3%, and net income climbed 21% to $20.9 million. Yet operating cash flow was cut in half year-over-year to $18.8 million as receivables swelled by $30.5 million, and cash reserves dwindled to $9 million. The company remains heavily reliant on two customers that represent nearly half of sales. Adding operational risk are a previously undisclosed February 2026 cyber incident and persistent labor issues at AJR. The balance sheet carries $117 million in debt, but the $150 million revolver provides a liquidity backstop. In sum, robust demand and margin gains are tempered by deteriorating cash conversion and concentration risk.

At the time of this filing, UFPT was trading at $311.87 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $2.4B. The 52-week trading range was $173.86 to $338.71. This filing was assessed with neutral market sentiment and an importance score of 8 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

UFPT - Latest Insights

UFPT
Aug 03, 2026, 4:27 PM EDT
Source: Reuters
Importance Score:
8
Price at Filing: $267.53
Real-time Price: $311.87 info
Change: +$44.34 (+17%) info
Market Cap: $2.413B info
UFPT
Aug 03, 2026, 4:12 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $267.53
Real-time Price: $311.87 info
Change: +$44.34 (+17%) info
Market Cap: $2.413B info
UFPT
Jun 10, 2026, 4:02 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $232.48
Real-time Price: $311.87 info
Change: +$79.39 (+34%) info
Market Cap: $2.413B info
UFPT
May 08, 2026, 4:03 PM EDT
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $230.55
Real-time Price: $311.87 info
Change: +$81.32 (+35%) info
Market Cap: $2.413B info
UFPT
May 04, 2026, 4:56 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $192.55
Real-time Price: $311.87 info
Change: +$119.32 (+62%) info
Market Cap: $2.413B info